Volume : 13, Issue : 04, April – 2026

Title:

IMPACT OF PHARMACIST INTERVENTIONS ON MEDICATION ADHERENCE IN POORLY CONTROLLED HYPERTENSIVE PATIENTS

Authors :

Maahin Rashed, Syeda Hajra Fatima, Amatul Raheem, Sarwath Jahan, Muazzam A Barbhuiya & Mohammad Shamim Qureshi*

Abstract :

Hypertension remains the single largest contributor to premature cardiovascular death globally. Despite the availability of effective antihypertensive agents, fewer than one in four patients achieve blood pressure (BP) control. Suboptimal medication adherence is a central driver of this treatment gap. This narrative review synthesises current evidence on the role of pharmacist-led interventions in improving medication adherence and BP control among poorly controlled hypertensive patients. Peer-reviewed systematic reviews, meta-analyses and randomised controlled trials published between 2010 and 2025 were examined. Evidence was organised around the types of pharmacist interventions, assessment tools used, and clinical outcomes reported. Pooled evidence from meta-analyses involving more than 30,000 patients demonstrates that pharmacist-led interventions produce mean systolic BP reductions of approximately 5–8 mmHg and diastolic reductions of 3–4 mmHg versus usual care. Multi-component strategies combining medication counselling, behavioural support, home BP monitoring, and collaborative prescribing consistently outperform single-component approaches. The pharmacist represents one of the most cost-effective human resources for closing the hypertension control gap. Integrating pharmacists into team-based hypertension care should be a policy priority, particularly in primary care and low-resource settings.
Keywords: Hypertension; medication adherence; pharmacist intervention; blood pressure control; pharmaceutical care; cardiovascular prevention.

Cite This Article:

Please cite this article in press Mohammad Shamim Qureshi et al., Impact Of Pharmacist Interventions On Medication Adherence In Poorly Controlled Hypertensive Patients, Indo Am. J. P. Sci, 2026; 13(04).

REFERENCES:

1. World Health Organization. Hypertension — Fact sheet. Geneva: WHO; 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension
2. World Health Organization. Global report on hypertension: the race against a silent killer. Geneva: WHO; 2023. p. 1–276.
3. Kibret KT, Yalew AW, Belaineh B, Asres MM. The global prevalence of uncontrolled hypertension: a systematic review and meta-analysis. BMC Public Health. 2025;25(1):2537.
4. Hamrahian SM, Maarouf OH, Fülöp T. A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider. Patient Prefer Adherence. 2022;16:2749–57.
5. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–80.
6. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982.
7. Oliveira-Filho AD, Morisky DE, Neves SJF, Costa FA, Lyra DP Jr. The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Social Adm Pharm. 2014;10(3):554–61.
8. Pandey A, Raza F, Velasco A, Brinker S, Ayers C, Das SR, et al. Comparison of Morisky Medication Adherence Scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens. 2015;9(6):420–6.
9. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
10. Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circ Res. 2019;124(7):1124–40.
11. Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Marešová V, et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017;69(6):1113–20.
12. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.
13. Gulayin P, Lopez-Saubidet I, Poggio R, Chaparro M, Beratarrechea A, Gibbons L, et al. Blood pressure association with the 8-item Morisky Medication Adherence Scale in hypertensive adults from low-resource primary care settings. Int J Clin Pharm. 2023;45(4):964–73.
14. Reeves L, Robinson K, McClelland T, Adedoyin CA, Broeseker A, Adunlin G. Pharmacist interventions in the management of blood pressure control and adherence to antihypertensive medications: a systematic review of randomized controlled trials. J Pharm Pract. 2021;34(3):480–92.
15. Cheema E, Sutcliffe P, Singer DRJ. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238–47.
16. Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, et al. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8(3):235–43.
17. Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2):e000718.
18. Viktoria G, Tancredi S, Kiszio B, Kambale Kavese A, Fadhil I, Santschi V, et al. Pharmacists delivering hypertension care services: a systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2025;12:1477729.
19. Mills KT, O’Connell SS, Pan M, Obst KM, He H, He J. Role of health care professionals in the success of blood pressure control interventions in patients with hypertension: a meta-analysis. Circ Cardiovasc Qual Outcomes. 2024;17(8):e010396.
20. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–67.
21. Zhang X, Wang T, Yu Y, Zhao S. Remote follow-up by pharmacists for blood pressure control in patients with hypertension: a systematic review and a meta-analysis of randomized controlled trials. Sci Rep. 2024;14(1):2483.
22. Pratama GA, Suwantika AA, Abdulah R, Puspitasari IM. Effectiveness of pharmacist-led intervention on medication adherence in chronic diseases: a systematic review of randomized controlled trials. Patient Prefer Adherence. 2025;19:2183–200.
23. Williams B, Akhter K, Clements L, Grant-Jacob JA, Ahmed S, Dzahini O, et al. Interventions to improve medication adherence in hypertensive patients: scoping review. Prev Med Rep. 2024;42:102712.
24. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241–53.
25. Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol. 2016;67(24):2846–54.